The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 62 | — | 20.1x | Near average | |
Growth | 49 | — | 5.6% | Near average | |
Quality | 20 | -33.3% | 7.6% | Below average | |
Safety | 35 | 9.3x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 98 | — | — | Above average | |
Sentiment | 35 | — | — | Near average |
Terns Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Terns Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
TERN stock has witnessed a notable divergence in analyst estimates; although the average price target rose by 4.63% to reach $58.13 over the past thirty days, this increase coincides with a series of rating downgrades by major institutions such as Oppenheimer and BMO Capital, which lowered their rating to 'Market Perform'. This discrepancy reflects a gap between the theoretical price target and actual confidence in the stock's future momentum.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.